Your browser doesn't support javascript.
loading
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Howard, James F; Bresch, Saskia; Farmakidis, Constantine; Freimer, Miriam; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Nowak, Richard J; Sivakumar, Kumaraswamy; Smilowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, Malgorzata; Bloemers, Jos; Boroojerdi, Babak; Brock, Melissa; de la Borderie, Guillemette; Duda, Petra W; Vanderkelen, Mark; Leite, M Isabel.
Afiliação
  • Howard JF; Department of Neurology, UNC School of Medicine, The University College of North Carolina at Chapel Hill, 2200 Houpt Building, CB#7025, 170 Manning Drive, Chapel Hill, NC 27599-7025, USA.
  • Bresch S; Service de Neurologie, Hospital Pasteur, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Farmakidis C; Neuromuscular Division, Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Freimer M; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Genge A; Clinical Research Unit, Montreal Neurological Institute, Montreal, QC, Canada.
  • Hewamadduma C; Academic Neuroscience Unit, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
  • Hinton J; Sheffield Institute for Translational Neurosciences (SITRAN), University of Sheffield, Sheffield, UK.
  • Hussain Y; Department of Neurology, Frederick P. Whiddon School of Medicine, University of South Alabama, Mobile, AL, USA.
  • Juntas-Morales R; Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
  • Kaminski HJ; Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Maniaol A; Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, DC, USA.
  • Mantegazza R; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Masuda M; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.
  • Nowak RJ; Department of Neurology, Tokyo Medical University, Tokyo, Japan.
  • Sivakumar K; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
  • Smilowski M; Neuromuscular Clinic and Research Center, Phoenix, AZ, USA.
  • Utsugisawa K; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland.
  • Vu T; Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
  • Weiss MD; Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Zajda M; Department of Neurology, University of Washington Medical Center, Seattle, WA, USA.
  • Bloemers J; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.
  • Boroojerdi B; UCB Pharma, Brussels, Belgium.
  • Brock M; UCB Pharma, Monheim am Rhein, Germany.
  • de la Borderie G; UCB Pharma, Raleigh, NC, USA.
  • Duda PW; UCB Pharma, Brussels, Belgium.
  • Vanderkelen M; UCB Pharma, Cambridge, MA, USA.
  • Leite MI; UCB Pharma, Braine-L'Alleud, Belgium.
Ther Adv Neurol Disord ; 17: 17562864241243186, 2024.
Article em En | MEDLINE | ID: mdl-38638673

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article